Theorem Clinical Research

Asia

SIRO Clinpharm named Indian CRO of the Year 2012

Monday, October 1, 2012 09:20 AM

SIRO Clinpharm, a drug development solutions provider, has been awarded the 'Indian CRO of the Year 2012' by Frost & Sullivan, a global growth partnership and consulting firm.

More... »

Quest Diagnostics

Novo Nordisk to expand R&D center in China

Tuesday, September 25, 2012 09:58 AM

Novo Nordisk, a Denmark-based biopharmaceutical company and the first multinational company to open a research center in China in 1997, is reaffirming its long-term commitment to the country by investing an additional $100 million to expand its state-of-the-art science facilities in Beijing.

More... »


Catalent Pharma and CTC BIO to partner in South Korea

Monday, September 17, 2012 11:21 AM

Catalent Pharma Solutions, a Somerset, N.J.-based developer of solutions and drug delivery technology, and CTC Bio, a drug and service provider based in Seoul, South Korea, have entered into a collaboration to provide optimal solutions to South Korean pharmaceutical companies seeking to commercialize solid oral dose and controlled release products in the U.S. and Europe.

More... »

INC Research expands in South Korea

Monday, September 17, 2012 09:27 AM

INC Research, a therapeutically focused CRO based in Raleigh, N.C., has opened a facility in Seoul, South Korea to manage the growing demand for world-class clinical development programs.

More... »

MedImmune, WuXi AppTec form joint venture to develop novel biologic for Chinese market

Monday, September 10, 2012 10:31 AM

MedImmune, the global biologics arm of AstraZeneca, and WuXi AppTec, an R&D outsourcing company, have formed a joint venture to develop and commercialize MEDI5117, a novel biologic for autoimmune and inflammatory diseases, in China.

More... »

Hospira to acquire API manufacturing and R&D facilities in India

Thursday, August 30, 2012 11:22 AM

Hospira, a global provider of injectable drugs and infusion technologies, has agreed to acquire an active pharmaceutical ingredient (API) manufacturing facility, together with an associated R&D facility, from Orchid Chemicals & Pharmaceuticals of India for approximately $200 million.

More... »

Medtronic establishes Shanghai Innovation Center

Wednesday, August 29, 2012 10:54 AM

Medtronic, a global medical technology company based in Minneapolis, Minn., has officially opened its Innovation Center in Shanghai, China.

More... »

Pfizer, Mylan ink exclusive long-term collaboration for generics in Japan

Thursday, August 23, 2012 02:02 PM

Global research-based pharmaceutical company Pfizer and Canonsburg, Penn.-based pharmaceutical company Mylan have signed a definitive agreement to establish an exclusive long-term strategic collaboration to develop, manufacture, distribute and market generic drugs in Japan.

More... »

PRA expands operations in China

Wednesday, August 22, 2012 01:10 PM

PRA, a global CRO, has opened a second office in China to accommodate its expansion in China and the Asia Pacific region.

More... »

India CRO market to earn $1B by 2016, says Frost & Sullivan

Monday, August 20, 2012 09:44 AM

The CRO market in India earned revenues of $485 million in 2010-11 and is estimated to cross $1.0 billion in 2016, according to new analysis from Frost & Sullivan, “Strategic Analysis of the Clinical Research Organization Market in India.”

More... »

`

CWWeekly

March 23

Industry welcomes FDA draft guidance outlining the use of electronic Informed Consent for trials

Apple launches ResearchKit platform to tap millions of iPhone users to enroll in observational studies using apps

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

March

Novo Nordisk, Takeda, Servier, Celgene among top sponsors
New gains seen from patient- and site-centric initiatives

Patient reported outcomes take center stage
FDA combining PROs, clinical outcomes in its approval decisions

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

February

Study grants market breaks $13 billion
Volume of clinical activity rising while growth in grant spending slows

Revisiting eClinical Technology Solutions Adoption
While use of established solutions grows, sponsors hesitate on newer tools

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs